Full-Time

Key Account Manager

Confirmed live in the last 24 hours

iRhythm Technologies

iRhythm Technologies

1,001-5,000 employees

Advanced cardiac monitoring solutions provider

Compensation Overview

$85k - $95k/yr

Mid, Senior

Columbus, OH, USA

Category
Strategic Account Management
Sales & Account Management
Required Skills
Salesforce
Requirements
  • Bachelor’s degree is highly preferred or an equivalent combination of education, training, and experience.
  • At least 3 years in an account management or customer success role supporting large or complex accounts.
  • Proven work experience as an Account Manager, Key Account Manager, and Sales Account Manager in a healthcare, medical device, or biotechnology environment.
  • Self-directed and proactive.
  • Demonstrable ability to communicate, present, and influence key stakeholders at all levels of an organization, including executive and C-level.
  • Ability to multi-task and prioritize in a fast-paced environment.
  • Proficiency with tools commonly used in a business environment including; CRM customer relationship management (Salesforce), reporting, and Microsoft Office.
  • Exceptionally collaborative, highly responsive, flexible, and adaptive.
  • Must be willing to travel up to 20%.
Responsibilities
  • Strategically partner with the iRhythm Sales organization to ensure the success of customers and patients within our large account segment.
  • Drive customer and account performance by monitoring and measuring activities including; registration volume, device inventory management, customer and patient satisfaction, clinical effectiveness, and workflow efficiency.
  • Serve as a primary point of contact for iRhythm internal teams regarding assigned customers.
  • Liaison with key stakeholders in billing, clinical operations, legal, finance, inventory, and customer care to ensure efficient account performance.
  • Train customers on the iRhythm service tools (ZioSuite, MyZio, etc.).
  • Act in a timely manner to resolve customer issues.
  • Provide continuous evaluation of processes and customer workflow.
  • Suggest new methods to create efficiencies through improved processes and additional technology.
  • Leverage iRhythm regional expertise as necessary.
  • Manage, onboard, and support assigned accounts.
  • Attend and support key customer meetings and sales Quarterly Business Review sessions.
  • Establish and maintain strong relationships with accounts and the internal sales organization.
  • Lead or participate in strategic initiatives within assigned accounts.
  • Conduct in-person account management initiatives as needed.
  • Monitor and communicate key performance trends across assigned accounts.
  • Work to develop action plans to improve account performance.
Desired Qualifications
  • Strong analytical skills with the ability to identify trends and present information succinctly and actionable.
  • Proven understanding of how to apply key performance measurements to drive commercial development.

iRhythm Technologies focuses on cardiac monitoring solutions, with its main product being the Zio Patch, a wearable device that tracks heart rhythms for up to 14 days. This extended monitoring helps healthcare providers detect irregular heart rhythms that shorter monitoring periods might miss. Patients can use the Zio Patch to monitor their heart activity conveniently, reducing the need for frequent office visits. iRhythm differentiates itself by offering comprehensive data analysis services alongside the device, enhancing diagnostic capabilities for healthcare providers.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

San Francisco, California

Founded

2006

Simplify Jobs

Simplify's Take

What believers are saying

  • iRhythm's expansion into Europe and Japan opens new market opportunities.
  • The wearable medical device market is growing at a 23.1% CAGR until 2030.
  • Integration with EHRs streamlines data sharing and improves patient care.

What critics are saying

  • Increased competition from AI-driven startups threatens iRhythm's market share.
  • FDA warning letter may lead to increased regulatory scrutiny.
  • Shareholder investigation for alleged securities fraud could have legal repercussions.

What makes iRhythm Technologies unique

  • Zio Patch offers up to 14 days of uninterrupted cardiac monitoring.
  • iRhythm integrates AI for predictive analytics in cardiac monitoring.
  • Zio Patch is the smallest and least conspicuous cardiac arrhythmia diagnostic device.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Mental Health Support

Hybrid Work Options

Pet Insurance

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

1%

2 year growth

1%
ETF Daily News
Mar 26th, 2025
Cibc World Markets Corp Invests $264,000 in iRhythm Technologies, Inc. (NASDAQ:IRTC)

Cibc World Markets Corp invests $264,000 in iRhythm Technologies, Inc. (NASDAQ:IRTC).

Investing.com
Feb 28th, 2025
iRhythm technologies' CBO and CLO Murphy sells $1.79 million in stock

Additionally, iRhythm is expanding internationally, with early launches in Europe and plans to enter the Japanese market in mid-2025.

Yahoo Finance
Jan 13th, 2025
Irhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights And Business Update At The 43Rd Annual J.P. Morgan Healthcare Conference

iRhythmSAN FRANCISCO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced preliminary fourth quarter operational highlights and a business update at the 43rd Annual J.P. Morgan Healthcare Conference.Recent Operational Highlights and Financial OutlookAnticipate full year 2024 revenue slightly above high end of previously stated guidance range of $587.5 million provided in October 2024Record quarter of new account openings for both Zio monitor and Zio AT during the fourth quarter 2024 as well as strong volume contributions from large national accountsLaunched first four health care systems on Epic Aura during the fourth quarter 2024 with broad commercial roll out for Epic health systems across the U.S. beginning in 2025Initiated Zio monitor shipments for home enrollment patients during the fourth quarter 2024Five studies presented at the American Heart Association highlight Zio Monitor’s high patient satisfaction, engagement and compliance with the patient MyZio app and digital tools, health economic impact of early arrhythmia detection in type 2 diabetes and respiratory disease, and AI insights on sleep and activity patterns 1Expect revenue for the full year 2025 of approximately $675 million to $685 million“This past year was a period of significant growth and transformation for iRhythm,” said Quentin Blackford, iRhythm’s President and CEO. “In our core U.S

MarketBeat
Nov 26th, 2024
Dynamic Technology Lab Private Ltd Invests $1.50 Million in iRhythm Technologies, Inc. (NASDAQ:IRTC)

Dynamic Technology Lab Private Ltd invests $1.50 million in iRhythm Technologies, Inc. (NASDAQ:IRTC).

MPO Magazine
Oct 22nd, 2024
iRhythm Earns FDA Nod for Zio AT After Warning Letter

The letter accused iRhythm of violating Federal Food, Drug, and Cosmetic Act rules about labeling, medical device reporting, and quality systems.